BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35016849)

  • 1. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19.
    Knight DRT; Munipalli B; Logvinov II; Halkar MG; Mitri G; Dabrh AMA; Hines SL
    Am J Med Sci; 2022 Apr; 363(4):295-304. PubMed ID: 35016849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital.
    Munipalli B; Ma Y; Li Z; Ganesh R; Knight D; Logvinov II; Paul SN; Delaney TR; Abu Dabrh AM
    J Investig Med; 2023 Dec; 71(8):896-906. PubMed ID: 37485961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
    Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
    Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia.
    Gwaikolo C; Sackie-Wapoe Y; Badio M; Glidden DV; Lindan C; Martin J
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38052015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort.
    Yoo SM; Liu TC; Motwani Y; Sim MS; Viswanathan N; Samras N; Hsu F; Wenger NS
    J Gen Intern Med; 2022 Jun; 37(8):1988-1995. PubMed ID: 35391623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.
    Sneller MC; Liang CJ; Marques AR; Chung JY; Shanbhag SM; Fontana JR; Raza H; Okeke O; Dewar RL; Higgins BP; Tolstenko K; Kwan RW; Gittens KR; Seamon CA; McCormack G; Shaw JS; Okpali GM; Law M; Trihemasava K; Kennedy BD; Shi V; Justement JS; Buckner CM; Blazkova J; Moir S; Chun TW; Lane HC
    Ann Intern Med; 2022 Jul; 175(7):969-979. PubMed ID: 35605238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Living like an empty gas tank with a leak": Mixed methods study on post-acute sequelae of COVID-19.
    Ogungbe O; Slone S; Alharthi A; Tomiwa T; Kumbe B; Bergman A; McNabb K; Smith Wright R; Farley JE; Dennison Himmelfarb CR; Cooper LA; Post WS; Davidson PM; Commodore-Mensah Y
    PLoS One; 2022; 17(12):e0279684. PubMed ID: 36584125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
    Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
    Elife; 2023 Feb; 12():. PubMed ID: 36748905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low growth hormone secretion associated with post-acute sequelae SARS-CoV-2 infection (PASC) neurologic symptoms: A case-control pilot study.
    Wright TJ; Pyles RB; Sheffield-Moore M; Deer RR; Randolph KM; McGovern KA; Danesi CP; Gilkison CR; Ward WW; Vargas JA; Armstrong PA; Lindsay SE; Zaidan MF; Seashore J; Wexler TL; Masel BE; Urban RJ
    Mol Cell Endocrinol; 2024 Jan; 579():112071. PubMed ID: 37816478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
    Peluso MJ; Kelly JD; Lu S; Goldberg SA; Davidson MC; Mathur S; Durstenfeld MS; Spinelli MA; Hoh R; Tai V; Fehrman EA; Torres L; Hernandez Y; Williams MC; Arreguin MI; Bautista JA; Ngo LH; Deswal M; Munter SE; Martinez EO; Anglin KA; Romero MD; Tavs J; Rugart PR; Chen JY; Sans HM; Murray VW; Ellis PK; Donohue KC; Massachi JA; Weiss JO; Mehdi I; Pineda-Ramirez J; Tang AF; Wenger M; Assenzio M; Yuan Y; Krone M; Rutishauser RL; Rodriguez-Barraquer I; Greenhouse B; Sauceda JA; Gandhi M; Hsue PY; Henrich TJ; Deeks SG; Martin JN
    medRxiv; 2021 Mar; ():. PubMed ID: 33758895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical differences in symptomology, characteristics, and risk factors in patients with post-acute sequelae of COVID-19: an experience from a tertiary-care academic center.
    Munipalli B; Paul S; Mohabbat A; Siddiqui H; Li Z; Abu Dabrh AM
    J Investig Med; 2023 Jun; 71(5):495-501. PubMed ID: 36760093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network.
    Iosifescu AL; Hoogenboom WS; Buczek AJ; Fleysher R; Duong TQ
    Int J Methods Psychiatr Res; 2022 Sep; 31(3):e1914. PubMed ID: 35706352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT.
    Bell ML; Catalfamo CJ; Farland LV; Ernst KC; Jacobs ET; Klimentidis YC; Jehn M; Pogreba-Brown K
    PLoS One; 2021; 16(8):e0254347. PubMed ID: 34347785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.